Data / Form D filings / Sincerus Pharmaceuticals Inc
Sincerus Pharmaceuticals Inc: Form D filing
Sincerus Pharmaceuticals Inc, a pharmaceuticals company in Pompano Beach, FL, filed a Form D with the SEC in 2019. The latest, on March 28, 2019, reports $505,504 sold of a $2 million offering to 24 investors.
Find out what Sincerus Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3265 W MCNAB ROAD, Pompano Beach, FL, 33069
- Phone
- (800) 604-5032
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1771772
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 28, 2019 | New notice | $2,000,000 | $505,504 | $1,494,496 | 24 | Mar 13, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Louis Jack Staley | Director | |
| Barret S. Malkin | Executive Officer, Director | |
| Michael S. Gleit | Director | |
| Jonathan G. Fenster | Executive Officer, Director | |
| Spencer J. Malkin | Executive Officer, Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Mar 25, 2019 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sincerus Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.